Trials / Conditions / Waldenstrom Macroglobulinaemia
Waldenstrom Macroglobulinaemia
5 registered clinical trials studyying Waldenstrom Macroglobulinaemia — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases. NCT07474961 | Anne Louise Tølbøll Sørensen | Phase 4 |
| Recruiting | This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinica NCT07160270 | Rigshospitalet, Denmark | — |
| Recruiting | SynKIR-310 for Relapsed/Refractory B-NHL NCT06544265 | Verismo Therapeutics | Phase 1 |
| Recruiting | Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing NCT06550427 | National Taiwan University Hospital | — |
| Completed | A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia NCT00811733 | GlaxoSmithKline | Phase 2 |